REQUEST A DEMO
Total
USD $0.00
Search more companies

Arvensis Bioscience S.R.O. (Slovakia)

Main Activities: Medical Equipment and Supplies Manufacturing | Surgical and Medical Instrument Manufacturing
Full name: Arvensis Bioscience S.R.O. Profile Updated: November 01, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Arvensis Bioscience S.R.O. is an enterprise based in Slovakia. Its main office is in Dunajska Streda. The company operates in the Medical Equipment and Supplies Manufacturing sector. The enterprise was incorporated on September 30, 2021. From the latest financial highlights, Arvensis Bioscience S.R.O. reported a net sales revenue increase of 4.1% in 2025. During that time, Arvensis Bioscience S.R.O.’s total assets grew by 34.79%.

Headquarters
Nova Ves, 2225/36
Dunajska Streda; Trnavsky; Postal Code: 92901

Contact Details: Purchase the Arvensis Bioscience S.R.O. report to view the information.

Basic Information
Registered Capital:
Purchase the Arvensis Bioscience S.R.O. report to view the information.
Financial Auditors:
Purchase the Arvensis Bioscience S.R.O. report to view the information.
Incorporation Date:
September 30, 2021
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Arvensis Bioscience S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
4.1%
Total Operating Revenue
3.98%
Operating Profit
-69.04%
EBITDA
-48.96%
Net Profit/Loss for the Period
N/A
Total Assets
34.79%
Total Equity
-1.71%
Operating Profit Margin
-1.75%
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
0.05%
Cash Ratio
-0.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?